Inactive Instrument
Mymetics Corporation Share Price Other OTC
Stocks
MYMX
US62856A1025
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4L 4L 4L 3L 6L 4.23Cr 6L 44.06L 17.14L 2.16Cr 16.47L 16.12L 6.93Cr | P/E 2021 |
-1.86x | P/E 2022 | -1.77x |
|---|---|---|---|---|---|
| Enterprise Value | 7.21Cr 6.43Cr 5.99Cr 5.46Cr 10Cr 694.59Cr 10Cr 72Cr 28Cr 354.51Cr 27Cr 26Cr 1.14TCr | EV / Sales 2021 |
177x | EV / Sales 2022 | 78x |
| Free-Float |
99.88% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 19/11/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.24% | +8.79% | - | - | 45 | |
| +4.16% | +3.42% | +49.37% | +94.17% | 7.43TCr | |
| +0.57% | -3.65% | +20.24% | +74.81% | 5.7TCr | |
| +2.05% | +0.82% | +5.67% | +37.25% | 4.83TCr | |
| -1.85% | +0.67% | +341.91% | +722.04% | 4.45TCr | |
| +2.32% | +1.38% | +33.01% | +37.28% | 4.38TCr | |
| +0.75% | -0.32% | +5.68% | +109.40% | 4.11TCr | |
| -0.54% | +2.41% | +9.31% | +58.85% | 3.11TCr | |
| +4.51% | +8.22% | +37.86% | +32.49% | 2.9TCr | |
| +0.15% | +1.20% | -5.14% | -10.30% | 2.45TCr | |
| Average | +0.27% | -0.15% | +55.32% | +128.44% | 4.37TCr | |
| Weighted average by Cap. | +1.63% | -0.46% | +59.09% | +136.82% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4L 4L 4L 3L 6L 4.14Cr 6L 43.18L 16.8L 2.11Cr 16.14L 15.79L 6.79Cr | 10.28L 9L 9L 8L 14.64L 9.9Cr 14.75L 1.03Cr 40.17L 5.05Cr 38.59L 37.76L 16Cr |
| Net income | -47.3L -42.2L -39.31L -35.78L -67.37L -46Cr -67.87L -4.75Cr -1.85Cr -23Cr -1.78Cr -1.74Cr -75Cr | -48.05L -42.87L -39.94L -36.34L -68.44L -46Cr -68.95L -4.83Cr -1.88Cr -24Cr -1.8Cr -1.76Cr -76Cr |
| Net Debt | 6.71Cr 5.99Cr 5.58Cr 5.08Cr 9.56Cr 646.22Cr 9.63Cr 67Cr 26Cr 329.82Cr 25Cr 25Cr 1.06TCr | 7.17Cr 6.39Cr 5.96Cr 5.42Cr 10Cr 690.37Cr 10Cr 72Cr 28Cr 352.35Cr 27Cr 26Cr 1.13TCr |
Employees
-
